yaboapp体育官网临床前肿瘤学
Advance your preclinical oncology compounds with a comprehensive suite of preclinical oncology studies, includingin vitro and in vivo pharmacology efficacy models, in vivoimaging technologies以及焦点radiationcapabilities.
Advance your next cancer research breakthrough.
当您的研究有可能挽救生命时,您应该通过非GLP,临床前发育和临床前发育和yaboapp体育官网oncology clinical trials快速有效地。
We've helped hundreds of companies discover their next life-improving compound.
细胞系和肿瘤模型
Browse hundreds of我们完整的细胞系列列表中的细胞系生长曲线或读我们的spotlights on tumor models。
免疫疗法和收养细胞疗法支持
We offer over 30 differentsyngeneic tumor models, from both solid and disseminated origins, to provide you with many choices to further your immuno-oncology research. We are continually improving and expanding adoptive cell therapy capabilities:
流式细胞术,成像和辐射
yaboapp体育官网临床前肿瘤资源
聚光灯:
LL/2: An Immunosuppressive Murine Tumor Model
肺癌是美国男女诊断的第二次常见癌症,并且到目前为止,男女癌症相关死亡原因最常见的原因。2019年,美国癌症协会估计,228,150例新肺癌病例(男性116,440人和女性111,710)。。。Read more about the LL/2 model
聚光灯:
B16-F10: A Murine Melanoma Model
皮肤癌包括所有层的癌,具有最常见的基础细胞(BCC)和鳞状细胞癌(SCC)。黑色素瘤和非黑色素瘤皮肤癌症(Merkel Cell Celcoma,Kaposi Sarcoma,皮肤淋巴瘤和其他肉瘤)都不常见。。。。Read more about a murine melanoma model
海报:
Preclinical Models of Multiple Myeloma
多发性骨髓瘤是一种克隆B细胞恶性肿瘤,其特征在于骨髓中末端分化,产生抗体的血浆细胞的积累,该骨髓中侵入性和耐药性。患者一般是无症状的直至非常晚期疾病。很少有突出的临床前模型,可延yaboapp体育官网长人类疾病。在这项工作中,我们已经评估了人类MM.1S模型和鼠5TGM1模型。。。阅读更多关于多发性骨髓瘤的临床前模型yaboapp体育官网
海报:
In-Depth Myeloid Cell Characterization in the Murine Syngeneic CT.26 Colon Carcinoma Model by 10-Color Flow Cytometry
The efficacy of immune-modulating anti-cancer therapeutic antibodies that have been FDA-approved in recent years, such as anti-CTLA-4 and anti-PD-1, has driven growing interest in methods that provide a mechanistic understanding of drug function. . .Read more about In-Depth Myeloid Cell Characterization
About Preclinical Oncology
2019年的景气欢迎临床前药理学肿瘤学提供者Mi Bioryaboapp体育官网esearch,进入Covance系列。您现在可以访问数百个细胞系测定和肿瘤模型,以及数千个潜力oncology patients for clinical trialsor explore an extensive library ofoncology diagnostics。
yaboapp体育官网临床前肿瘤事件
- AACR|24-29 April | San Diego, CA
- Nonclinical Drug Symposium|5月6日至7日,德国